Medibio is the World’s First Developer of an objective test for the diagnosis of depression and other Mental Health disorders.
On track to commercialise our platform technology, the Digital Mental Health Platform which is based on patented biomarkers from the autonomic nervous system.
Depression is a global epidemic with insufficient psychiatrists, where GPs become the front liners for mental health diagnosis which is often inefficient. Medibio’s technology will provide a Diagnosis Aid to assist GP’s and mental health clinicians.
BIOMARKER BASED OBJECTIVE DIAGNOSIS
Panel of circadian, sleep and automatic system biomarkers enables automated, repeatable, and objective characterization of the impact of mental illness on physiologic state